Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140
- 31 August 1994
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 58 (2) , 478-482
- https://doi.org/10.1016/0003-4975(94)92233-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Changes in neutrophil CD11b/CD18 andl-selectin expression and release of interleukin 8 and elastase in paediatric cardiopulmonary bypassInflammation Research, 1993
- Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.Heart, 1993
- Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1992
- Characterization of GMP-140 (P-selectin) as a circulating plasma protein.The Journal of Experimental Medicine, 1992
- Onset and evolution of pulmonary vascular disease in young children: Abnormal postnatal remodelling studied in lung biopsiesThe Journal of Pathology, 1992
- Adhesion receptors of the immune systemNature, 1990
- Prevention of Activated Neutrophil Adhesion to Endothelium by Soluble Adhesion Protein GMP140Science, 1990
- GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.Journal of Clinical Investigation, 1989
- A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.The Journal of cell biology, 1985
- The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension.Circulation, 1979